Volastra Therapeutics, Inc. — Form D

Volastra Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-23. The offering totals $30.1M, of which $30.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Samuel BakhoumDirectorNEW YORK, NY
Arjun BalarDirectorNEW YORK, NY
Luc DochezDirectorNEW YORK, NY
Jill GoldsteinDirectorNEW YORK, NY
Ellie McGuireDirectorNEW YORK, NY
Robert MittendorffDirectorSAN FRANCISCO, CA
David NicholsonDirectorCarlsbad, CA
Sandra PetersonDirectorNEW YORK, NY
David SouthwellDirectorNEW YORK, NY
David SouthwellExecutive OfficerNEW YORK, NY
Amy SchulmanDirectorCambridge, MA
Sandra PetersonExecutive OfficerNEW YORK, NY
Arjun Zolot BalarDirectorNew York, NY
Stefan Zolot VitorovicDirectorNew York, NY
Eileen Zolot McGuireDirectorNew York, NY
Rachel Zolot SchwartzExecutive OfficerNew York, NY
Samuel Zolot BakhoumDirectorNew York, NY
Scott DrutmanExecutive OfficerNew York, NY
Charles Hugh-JonesDirectorNew York, NY
Charles Hugh-JonesExecutive OfficerNew York, NY
David Zolot NicholsonDirectorNew York, NY
Sandra Zolot PetersonDirectorNew York, NY
Rez Zolot HalzeDirectorNew York, NY
Diane TagerExecutive OfficerNew York, NY
Michael SuExecutive OfficerNew York, NY

Other filings by this issuer (2)

FiledFormOfferingSold
2024-05-30D$15.0M$15.0M
2023-03-13D$60.2M$60.2M

More